Orchid Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter IV of F.Y.2024-25
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has submitted a compliance certificate to the stock exchange as required under Regulation 74(5) of SEBI's Depositories and Participants Regulations, 2018. This regulation requires the company's Registrar and Share Transfer Agent (RTA) to confirm every quarter that all share dematerialisation (demat) requests received from shareholders have been properly processed — either credited to their demat accounts or rejected with reasons — within the timeline prescribed by SEBI. The filing covers the fourth quarter of the financial year ending March 2025. This is a standard quarterly compliance obligation and does not involve any new corporate action, financial result, or change in the company's capital structure.
This is a routine regulatory filing with no material impact on the company's financials, operations, or shareholder value. Investors can safely ignore this announcement as it carries no trading or investment signal.